HWM
ATHE

HB Wealth Management’s Alterity Therapeutics ATHE Stock Holding History

HB Wealth Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Hold
58,460
– – ﹤0.01% 1354
2026
Q1 		$203K Hold
58,460
– – ﹤0.01% 1436
2025
Q4 		$180K Hold
58,460
– – ﹤0.01% 1340
2025
Q3 		$220K Buy
+58,460
New +$282K ﹤0.01% 1225
2025
Q2 		– Sell
-37,483
Closed -$129K – 1173
2025
Q1 		$129K Buy
37,483
+5,600
+18% +$21.5K ﹤0.01% 1165
2024
Q4 		$110K Buy
31,883
+8,100
+34% +$12.9K ﹤0.01% 1023
2024
Q3 		$31.2K Buy
+23,783
New +$35K ﹤0.01% 960

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

HB Wealth Management's ATHE Position: Q2 2026 in Review

HB Wealth Management held its Alterity Therapeutics (ATHE) position steady in Q2 2026 at 58,460 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

HB Wealth Management first reported a position in ATHE in Q3 2024 and has held it in 7 quarters since. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • HB Wealth Management held 58,460 shares of Alterity Therapeutics worth $314K as of Q2 2026.
  • HB Wealth Management left its Alterity Therapeutics share count unchanged in Q2 2026.
  • Alterity Therapeutics made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1354 holding.
  • HB Wealth Management first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.